Literature DB >> 1106764

The induction of obesity in rodents by means of monosodium glutamate.

J Bunyan, E A Murrell, P P Shah.   

Abstract

1. Monosodium glutamate (MSG) was administered by various methods to mice and rats of various ages and the incidence of obesity was later measured. 2. Newborn mice were injected subcutaneously with 3 mg MSG/g body-weight at 1, 2, 3, 6, 7, and 8 d of age; 16% died before weaning. Of the survivors, 90% or more became markedly obese. Mean carcass lipid content was increased by about 120% in both sexes at 20-30 weeks old. In male mice, MSG treatment increased body-weight and epididymal fat pad weight, and greatly decreased adrenaline-stimulated lipolysis in isolated fat cells. Body-eright of females was not increased significantly. Food intake was not increased in either sex from weeks 13 to 15. Blood glucose level was not generally increased by MSG but some of the male mice had abnormally high values. 3. Obesity was not detected in the offspring of female mice that had received 100 g MSG/kg diet, either from 3 weeks before mating until weaning, or from the 14th day of pregnancy until weaning. 4. Intraperitoneal injection of 10 mg MSG/g body-weight (in two doses) at weaning increased carcass lipid content in female mice by 34% by 23 weeks of age, but female rats were not affected. 5. The addition of 20 g MSG/l to the drinking-water from weaning onwards did not increase carcass lipid content in female rats or mice. 6. The addition of 20 g MSG/kg diet from weaning onwards did not alter body-weight or carcass lipid content in male and female rats by 14 weeks of age. 7. The obesity induced in mice by MSG was not associated with hyperphagia, unlike genetic obesity and obesity induced by gold thioglucose (GTG). 8. All types of mouse studied, obese and lean, had essentially the same linear relationship between carcass water content and carcass lipid content. 9. Although MSG-obese mice could not readily be differentiated from normal mice by the increase in body-weight, which was only about 10% compared to 50-120% for genetic and GTG-induced obesity, the proposed schedule of injections in the newborn was almost 100% reliable in inducing a high extent of adiposity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1106764     DOI: 10.1079/bjn19760005

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  22 in total

Review 1.  Risk Assessment Paradigm for Glutamate.

Authors:  Ashley Roberts; Barry Lynch; Ivonne M C M Rietjens
Journal:  Ann Nutr Metab       Date:  2018-12-03       Impact factor: 3.374

2.  Genomewide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. Pima Diabetes Gene Group.

Authors:  R A Norman; D B Thompson; T Foroud; W T Garvey; P H Bennett; C Bogardus; E Ravussin
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

3.  Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention.

Authors:  Ruixin Liu; Jie Hong; Xiaoqiang Xu; Qiang Feng; Dongya Zhang; Yanyun Gu; Juan Shi; Shaoqian Zhao; Wen Liu; Xiaokai Wang; Huihua Xia; Zhipeng Liu; Bin Cui; Peiwen Liang; Liuqing Xi; Jiabin Jin; Xiayang Ying; Xiaolin Wang; Xinjie Zhao; Wanyu Li; Huijue Jia; Zhou Lan; Fengyu Li; Rui Wang; Yingkai Sun; Minglan Yang; Yuxin Shen; Zhuye Jie; Junhua Li; Xiaomin Chen; Huanzi Zhong; Hailiang Xie; Yifei Zhang; Weiqiong Gu; Xiaxing Deng; Baiyong Shen; Xun Xu; Huanming Yang; Guowang Xu; Yufang Bi; Shenghan Lai; Jian Wang; Lu Qi; Lise Madsen; Jiqiu Wang; Guang Ning; Karsten Kristiansen; Weiqing Wang
Journal:  Nat Med       Date:  2017-06-19       Impact factor: 53.440

4.  The neurotherapeutic role of a selenium-functionalized quinoline in hypothalamic obese rats.

Authors:  Ethel Antunes Wilhelm; Cristiane Luchese; Karline C Rodrigues; Cristiani F Bortolatto; Ketlyn P da Motta; Renata L de Oliveira; Jaini J Paltian; Roberta Krüger; Silvane S Roman; Silvana P Boeira; Diego Alves
Journal:  Psychopharmacology (Berl)       Date:  2021-03-19       Impact factor: 4.530

Review 5.  Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity.

Authors:  Amanda Janesick; Bruce Blumberg
Journal:  Birth Defects Res C Embryo Today       Date:  2011-03

6.  Screening of stimulatory effects of dietary risk factors on mouse intestinal cell kinetics.

Authors:  Pooja Shivshankar; Shyamala-C-S Devi
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

7.  Effects of administration of sodium glutamate during the neonatal period on behavior and blood corticosterone levels in male mice.

Authors:  E G Kuznetsova; T G Amstislavskaya; V V Bulygina; S I Il'nitskaya; M A Tibeikina; Yu A Skrinskaya
Journal:  Neurosci Behav Physiol       Date:  2007-10

8.  The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

Authors:  Anna Secher; Jacob Jelsing; Arian F Baquero; Jacob Hecksher-Sørensen; Michael A Cowley; Louise S Dalbøge; Gitte Hansen; Kevin L Grove; Charles Pyke; Kirsten Raun; Lauge Schäffer; Mads Tang-Christensen; Saurabh Verma; Brent M Witgen; Niels Vrang; Lotte Bjerre Knudsen
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

9.  Monosodium glutamate accelerates migration of hypothalamic perikarya at puberty.

Authors:  E Marani; W J Rietveld; M E Boon
Journal:  Histochemistry       Date:  1982

10.  Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency?

Authors:  A E Stevenson; B A J Evans; E F Gevers; C Elford; R W J McLeod; M J Perry; M M El-Kasti; K T Coschigano; J J Kopchick; S L Evans; T Wells
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-11       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.